Market Overview

NuVasive to Release $62.5M from Escrow Following Appeals Court Win

Share:
Related NUVA
Piper Jaffray Met With NuVasive Management And Came Away 'Still Confident'
Goldman Sachs' New Pair Trade? Bull Zeltiq Aesthetics, Bear NuVasive
NuVasive Hits 7-Year High After Q2 Earnings Beat (Investor's Business Daily)

NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today the release of $62.5 million from a restricted escrow account in relation to NuVasive's trademark dispute regarding the NeuroVision(R) trade name.

Posted-In: News Legal

 

Related Articles (NUVA)

Get Benzinga's Newsletters